Total Return chart Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 18/06/2025			5-day change	1st Jan Change
162,300.00 ^KRW	+0.31%		+0.06%	-9.98%

06-16	Celltrion, Inc. Announces U.S. FDA Approval of Additional Presentation of Steelara®? (Ustekinumab-Stba)	CI
05-27	South Korean Shares Slip on Profit-Booking; Korea Zinc Loses 4% on KFTC Probe	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.